UnitedHealth Group Incorporated (NYSE:UNH) Position Trimmed by E. Ohman J or Asset Management AB

E. Ohman J or Asset Management AB decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 4.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 39,955 shares of the healthcare conglomerate's stock after selling 2,015 shares during the period. E. Ohman J or Asset Management AB's holdings in UnitedHealth Group were worth $20,926,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of UNH. Capital & Planning LLC grew its position in shares of UnitedHealth Group by 19.2% during the fourth quarter. Capital & Planning LLC now owns 491 shares of the healthcare conglomerate's stock worth $248,000 after acquiring an additional 79 shares during the last quarter. Brighton Jones LLC grew its position in UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after buying an additional 28,231 shares in the last quarter. Union Bancaire Privee UBP SA bought a new position in UnitedHealth Group in the 4th quarter valued at about $27,233,000. Revolve Wealth Partners LLC grew its position in UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after buying an additional 2,324 shares in the last quarter. Finally, Money Concepts Capital Corp grew its position in UnitedHealth Group by 1.4% in the 4th quarter. Money Concepts Capital Corp now owns 3,800 shares of the healthcare conglomerate's stock valued at $1,922,000 after buying an additional 54 shares in the last quarter. Institutional investors own 87.86% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the stock. Oppenheimer decreased their target price on shares of UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating for the company in a research report on Wednesday, May 14th. JPMorgan Chase & Co. cut their price target on shares of UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating for the company in a report on Thursday, May 15th. Royal Bank of Canada cut their price target on shares of UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating for the company in a report on Friday, May 16th. Hsbc Global Res downgraded shares of UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a report on Wednesday, May 21st. Finally, TD Cowen downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price target for the company. in a report on Monday, May 19th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and seventeen have given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $428.43.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn acquired 1,533 shares of the stock in a transaction dated Wednesday, May 14th. The shares were acquired at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the purchase, the director now owns 6,033 shares in the company, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Kristen Gil acquired 3,700 shares of the stock in a transaction dated Thursday, May 15th. The stock was bought at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the purchase, the director now owns 3,818 shares of the company's stock, valued at $1,035,327.06. The trade was a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased a total of 109,408 shares of company stock worth $31,607,768 over the last 90 days. Insiders own 0.33% of the company's stock.

UnitedHealth Group Price Performance

Shares of UNH opened at $295.61 on Friday. The firm has a market cap of $268.16 billion, a PE ratio of 19.07, a PEG ratio of 1.37 and a beta of 0.56. The firm's 50 day moving average price is $413.43 and its 200 day moving average price is $486.09. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period in the previous year, the business posted $6.91 EPS. As a group, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.99%. The ex-dividend date is Monday, June 16th. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio (DPR) is 35.18%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.